Trials / Recruiting
RecruitingNCT07083765
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
A Prospective Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation Using the Dehydrated Alcohol Injection, USP Administered With the Peregrine System™ Infusion Catheter in Subjects With Hypertension, in the Absence of Antihypertensive Medications
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 142 (estimated)
- Sponsor
- Ablative Solutions, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To obtain an assessment of the efficacy and safety of renal denervation by dehydrated alcohol injection, USP administered via the Peregrine System™ Infusion Catheter in hypertensive subjects in the absence of antihypertensive medications.
Detailed description
This Phase 3, prospective, randomized, blinded, sham procedure-controlled, multicenter study will assess the efficacy and safety of renal denervation by alcohol-mediated neurolysis using the Peregrine Catheter in hypertensive subjects in the absence of antihypertensive medications. Subjects with a documented history of uncontrolled hypertension who are taking 0, 1, or 2 antihypertensive medications at enrollment will be recruited. After providing written informed consent, subjects will undergo screening assessments to assess eligibility for the study. Eligible subjects will then enter a run in period during which they will take no antihypertensive medications. Subjects who continue to be eligible at the end of the run-in period will complete the study Baseline visit and remain without taking antihypertensive medications. Subjects who continue to be eligible after the completion of the Baseline visit will attend the study site and will be randomized to either the Treatment Arm (renal denervation using the Peregrine Catheter) or the Sham Control Arm (renal angiography only). After study unblinding, crossover from the Sham Control Arm to the Treatment Arm may be allowed, at the discretion of the treating investigator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dehydrated Alcohol Injection, USP | Alcohol is directly infused/delivered to the adventitial and periadventitial space of the renal arteries |
| PROCEDURE | Sham procedure | Endovascular, renal angiography |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2027-06-01
- Completion
- 2027-10-31
- First posted
- 2025-07-24
- Last updated
- 2025-09-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07083765. Inclusion in this directory is not an endorsement.